Eubanks Richard M.

Row 1 · 2026-09-30 · Grant · Acquired 118 · Balance 47,542.45

F1: Program Units (each of which is the economic equivalent of one share of The Brink's Company ("BCO") common stock) credited to the Reporting Person's stock incentive account under the terms of the Key Employees' Deferral Compensation Program (the "Program") will settle in BCO common stock on a one-for-one basis and shall be distributed in accordance with the Reporting Person's deferral election either (1) following the Reporting Person's termination of employment with BCO or (2) on a future date selected by the Reporting Person at the time of his or her deferral election.

F2: In accordance with the terms of the Program, on the last business day of each month, compensation deferred by the Reporting Person during that month and/or any matching amounts are converted into Program Units and credited to the Reporting Person's stock incentive account.

F3: The number of Program Units credited to the Reporting Person's account on the transaction date is based upon a share price of $100.99, which is the closing price of BCO common stock on the final trading day of the month in which the deferred compensation would have been payable, calculated in accordance with the terms of the Program.

Row 1 · 2019-03-12 · Sale · Disposed 18,894 · Balance 20,204

F1: Price reported constitutes the average weighted price of shares sold. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Row 2 · 2019-03-12 · Exercise / conversion · Acquired 1,326 · Balance 21,530

Row 3 · 2019-03-12 · Tax withholding · Disposed 1,240 · Balance 20,290

Row 4 · 2019-03-12 · Exercise / conversion · Acquired 4,924 · Balance 25,214

Row 5 · 2019-03-12 · Sale · Disposed 4,924 · Balance 20,290

Row 6 · 2019-03-12 · Exercise / conversion · Acquired 1,395 · Balance 21,685

Row 7 · 2019-03-12 · Tax withholding · Disposed 1,240 · Balance 20,445

Row 8 · 2019-03-12 · Exercise / conversion · Acquired 7,155 · Balance 27,600

Row 9 · 2019-03-12 · Sale · Disposed 7,155 · Balance 20,445

Row 10 · 2019-03-12 · Exercise / conversion · Acquired 1,768 · Balance 22,213

Row 11 · 2019-03-12 · Tax withholding · Disposed 1,239 · Balance 20,974

Row 12 · 2019-03-12 · Exercise / conversion · Acquired 7,276 · Balance 28,250

Row 13 · 2019-03-12 · Sale · Disposed 7,276 · Balance 20,974

Row 14 · 2019-03-12 · Exercise / conversion · Acquired 14,949 · Balance 35,923

Row 15 · 2019-03-12 · Sale · Disposed 14,949 · Balance 20,974

F1: Price reported constitutes the average weighted price of shares sold. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Row 16 · 2019-03-12 · Exercise / conversion · Disposed 1,326 · Balance 4,924

F2: These options were granted on February 25, 2014, and are fully vested and exercisable.

Row 17 · 2019-03-12 · Exercise / conversion · Disposed 4,924 · Balance 0

F2: These options were granted on February 25, 2014, and are fully vested and exercisable.

Row 18 · 2019-03-12 · Exercise / conversion · Disposed 1,395 · Balance 7,155

F3: These options were granted on February 24, 2015, and are exercisable as follows: 33% on the first and second anniversaries of the grant date and 34% on the third anniversary of the grant date.

Row 19 · 2019-03-12 · Exercise / conversion · Disposed 7,155 · Balance 0

F3: These options were granted on February 24, 2015, and are exercisable as follows: 33% on the first and second anniversaries of the grant date and 34% on the third anniversary of the grant date.

Row 20 · 2019-03-12 · Exercise / conversion · Disposed 1,768 · Balance 7,276

F4: These options were granted on February 23, 2016, and are exercisable as follows: 33% on the first and second anniversaries of the grant date and 34% on the third anniversary of the grant date.

Row 21 · 2019-03-12 · Exercise / conversion · Disposed 7,276 · Balance 0

F4: These options were granted on February 23, 2016, and are exercisable as follows: 33% on the first and second anniversaries of the grant date and 34% on the third anniversary of the grant date.

Row 22 · 2019-03-12 · Exercise / conversion · Disposed 14,949 · Balance 7,701

F5: These options were granted on February 21, 2017, and are exercisable as follows: 33% on the first and second anniversaries of the grant date and 34% on the third anniversary of the grant date.

Row 1 · 2026-09-24 · Grant · Acquired 1,802 · Balance 1,802

F1: On September 24, 2026, the Reporting Person was awarded a total of 1,802 restricted share units ("RSUs") pursuant to the terms of the annual equity award to Non-Employee Directors under the Issuer's Amended and Restated 2017 Equity Incentive Plan as more fully described in the section titled "Fiscal Year 2026 Non-Employee Directors' Compensation" beginning on page 24 of the Issuer's Proxy Statement filed with the SEC on June 24, 2026. The award shall vest in full on the date immediately prior to the date of the Issuer's 2027 annual general meeting.

F2: Consists of 1,802 unvested RSUs which shall vest in full on the date immediately prior to the date of the Issuer's 2027 annual general meeting. Each unvested RSU represents a contingent right to receive one unrestricted, fully transferable share for each vested RSU which has not previously forfeited.

Row 1 · 2020-06-01 · Grant · Acquired 19,800 · Balance 19,800

F1: Each Founders Grant RSU represents the contingent right to receive one share of Otis common stock upon the vesting date of June 1, 2023. RSUs accumulate dividend equivalents that are payable in common stock upon vesting.